Inaktiver Wert

Andere Sprachen Kiadis Pharma N.V.

Aktien

Sanofi : Delays Privatization of Kiadis on Pending Mandatory Buy-Out	16.07.21
Pharming benoemt Chief Medical Officer	18.06.21
Certain Ordinary Shares of Kiadis Pharma N.V. are subject to a Lock-Up Agreement Ending on 31-MAY-2021.	31.05.21
Kiadis Pharma N.V.(ENXTAM:KDS) dropped from Next Biotech Index	24.05.21
Kiadis Pharma N : - Notice of Annual General Meeting of Shareholders	14.05.21
Kiadis Pharma N : AGM QA Protocol	13.05.21
Kiadis Pharma N : AGM Agenda	13.05.21
Kiadis Pharma N : AGM Proxy	13.05.21
Sanofi : to Delist Kiadis in Amsterdam, Brussels on May 25	29.04.21
Bijna alle aandelen Kiadis aangemeld onder bod Sanofi	29.04.21
Final results of the Offer for Kiadis: 97.39% of Kiadis Shares in total committed under the Offer	29.04.21
Sanofi : to Delist Kiadis from Euronext on May 25	27.04.21
Sanofi : completes Kiadis acquisition	19.04.21
Sanofi : Closes $368 Million Purchase of Kiadis	19.04.21
Sanofi rondt bod op Kiadis af	16.04.21
Sanofi boucle son OPA amicale sur la biotech néerlandaise Kiadis	16.04.21
Kiadis Pharma N : Minutes of the EGM held on 30 March 2021	14.04.21
Kiadis Pharma N.V.(ENXTAM:KDS) dropped from Netherlands ASCX AMS Small Cap Index	14.04.21
Sanofi : Declares Kiadis Offer Unconditional, All Offer Conditions Now Satisfied	13.04.21
Sanofi : Declares Offer for Immunotherapy Company Kiadis Unconditional	13.04.21

Keine Ergebnisse zu dieser Suche